Department of Medical Oncology, St. Bartholomew's Hospital

London EC1A 7BE

0 studies enrolling now · 2 studies all time

What they study most

Kidney Neoplasms, Lymphoma, Non-Hodgkin

Studies at this site

• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early